The immunology field has recently become one of the hottest areas in the biopharma industry, attracting a major wave of investment over the past couple of years. In fact, there have already been more than 10 buyouts of immunology and inflammation (I&I) drug developers this year from some of the biggest names in pharma and biotech, and multiple immunology companies have recently launched and raised impressive financing rounds to advance the development of their drugs. In this article, we…
Read More…
Source: https://www.labiotech.eu/best-biotech/immunology-biotech-companies/